Response to "On the choice of methodology for evaluating dose-rate effects on radiation-related cancer risks" by Walsh et al
Radiat Environ Biophys
.
2021 Nov;60(4):515-516.
doi: 10.1007/s00411-021-00935-5.
Epub 2021 Aug 17.
Authors
Mark P Little
1
,
David J Pawel
2
,
Kossi Abalo
3
,
Michael Hauptmann
4
Affiliations
1
Radiation Epidemiology Branch, National Cancer Institute, 9609 Medical Center Drive, Bethesda, MD, 20892-9778, USA. mark.little@nih.gov.
2
Office of Radiation and Indoor Air, Environmental Protection Agency, 1200 Pennsylvania Avenue, NW, Washington, DC, 20460, USA.
3
Laboratoire d'Épidémiologie, Institut de Radioprotection et de Sûreté Nucléaire, BP 17, 92262, Fontenay-aux-Roses Cedex, France.
4
Institute of Biostatistics and Registry Research, Brandenburg Medical School Theodor Fontane, Fehrbelliner Strasse 38, 16816, Neuruppin, Germany.
PMID:
34401930
PMCID:
PMC10681271
DOI:
10.1007/s00411-021-00935-5
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Neoplasms* / etiology
Grants and funding
Z99 CA999999/ImNIH/Intramural NIH HHS/United States